HIV & AIDS

Despite cART, anal cancer risk still high for HIV-infected

(HealthDay)—For HIV-infected patients, despite combined antiretroviral treatment (cART), the risk of anal cancer is still much higher than in the general population, according to a study published in the Dec. 10 issue of ...

Oncology & Cancer

Study helps resolve debate about how tumors spread

A team of scientists, led by researchers at the University of California, San Diego School of Medicine, has shown for the first time how cancer cells control the ON/OFF switch of a program used by developing embryos to effectively ...

Oncology & Cancer

Screening the sun: We still need to cover up, researchers say

(Medical Xpress)—Covering up and staying out of the sun for prolonged periods of time, especially in the middle of the day, is still the best way to protect ourselves from damaging ultraviolet (UV) radiation, claims a University ...

Cardiology

Diltiazem relieves capecitabine-induced chest pain

(HealthDay)—Secondary prophylaxis with diltiazem may offer cancer patients relief from capecitabine-induced chest pain and dyspnea and allow them to tolerate capecitabine treatment, according to a study published in the ...

Oncology & Cancer

Study shows bone metastases treatment can improve overall survival

It is common for patients initially diagnosed with lung cancer to have the cancer spread to sites like the liver, brain and bone. One of the most frequent sites of metastases is the bone, with an estimated 30 to 40 percent ...

Oncology & Cancer

Gene signature validated for oral cancer metastases

(HealthDay)—A multigene signature effectively predicts the presence of lymph node metastases in squamous cell carcinoma of the oral cavity (OSCC) and oropharynx (OPSCC), according to a study published online Oct. 8 in the ...

page 35 from 40